Analyst lowers expectations for Novo Nordisk after Lilly’s new weight-loss study

Intron Health and wellness is decreasing its price quotes for Novo Nordisk by 2030. Sales price quotes have actually been reduced by 20%, while profits per share assumptions have actually been reduced by 25%.

发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/analyst-lowers-expectations-for-novo-nordisk-after-lillys-new-weight-loss-study/

(0)
上一篇 23 4 月, 2025 3:18 上午
下一篇 23 4 月, 2025 3:18 上午

相关推荐

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。